These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 504102)

  • 41. [Results of polychemotherapy in patients with newly detected destructive pulmonary tuberculosis].
    Berezovskiĭ BA; Popova II; Pshevorskiĭ VIa
    Probl Tuberk; 1990; (4):50-2. PubMed ID: 2118644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Experience with intensive short-term chemotherapy of patients with recently diagnosed destructive pulmonary tuberculosis].
    Porokhnia VV; Khomenko VV; Petrovich DI; Iusukhno EE; Skvira VP
    Probl Tuberk; 1989; (3):64-7. PubMed ID: 2726715
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of pulmonary tuberculosis by the inhalation of aerosols of antibacterial preparations and pathogenetic agents].
    Kulik NM
    Probl Tuberk; 1980 Jan; (1):40-2. PubMed ID: 6899947
    [No Abstract]   [Full Text] [Related]  

  • 44. [Ethambutol, capreomycin and rifampicin in lung tuberculosis].
    Hellström PE; Repo UK
    Nord Med; 1968 Dec; 79(51):1723-9. PubMed ID: 5712754
    [No Abstract]   [Full Text] [Related]  

  • 45. [Late results of 12-month-long hospital treatment of chronic pulmonary tuberculosis with rifampicin combined with other antitubercular agents].
    Danilczuk R; Piekarniak K; Wyczólkowski M; Martyniak K
    Pneumonol Pol; 1977 Feb; 45(2):125-30. PubMed ID: 840724
    [No Abstract]   [Full Text] [Related]  

  • 46. [Combining antitubercular agents of similar hepatic toxicity].
    Niemirowska H; Pecyna-Sielewicz J; Styszewska H; Wareska W
    Gruzlica; 1975 Jan; 43(1):37-46. PubMed ID: 1110038
    [No Abstract]   [Full Text] [Related]  

  • 47. [Intermittent chemotherapy of patients with fibrous-cavernous pulmonary tuberculosis in a hospital].
    Kovalenko NN; Ginzburg TS; Kunichkina SA
    Probl Tuberk; 1987; (11):35-7. PubMed ID: 3125538
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effectiveness of chemotherapy of patients with newly detected destructive pulmonary tuberculosis living in rural areas].
    Strutinskiĭ MI; Strakhov NS
    Probl Tuberk; 1990; (7):31-3. PubMed ID: 2235947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effectiveness of the chemotuberculinotherapy of patients with destructive pulmonary tuberculosis].
    Il'nitskiĭ IG
    Probl Tuberk; 1985; (4):36-8. PubMed ID: 4001106
    [No Abstract]   [Full Text] [Related]  

  • 50. [On the results of treatment of secondary pulmonary tuberculosis in patients discovered in the year 1967].
    Chiriac T; Scriitoru E; Ionescu A; Prodan A
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(4):903-8. PubMed ID: 5164531
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effectiveness of different chemotherapy regimens in newly detected patients with destructive pulmonary tuberculosis].
    Omarov TO; Shefer LB; V'iushkova SV; Abzharkenova ESh
    Probl Tuberk; 1987; (4):15-7. PubMed ID: 3601919
    [No Abstract]   [Full Text] [Related]  

  • 52. [Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus].
    Kameda K; Kawabata S; Masuda N
    Kekkaku; 1990 Dec; 65(12):791-803. PubMed ID: 2077255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Adverse reactions during intravenous drop chemotherapy of disseminated fibrous-cavernous pulmonary tuberculosis].
    Milinder NM
    Sov Med; 1979 Nov; (11):64-7. PubMed ID: 524200
    [No Abstract]   [Full Text] [Related]  

  • 54. [Side effects of antitubercular drug therapy in combination with prednisolone].
    Shmelev NA; Stepanian ES; Gedymin LE; Lukíanova LA
    Sov Med; 1976 Apr; (4):116-9. PubMed ID: 982126
    [No Abstract]   [Full Text] [Related]  

  • 55. [Long-term results of short-course chemotherapy of pulmonary tuberculosis (second study--A). Results up to 6 years after the end of treatment with 4-6 month chemotherapy of pulmonary tuberculosis].
    Baba H; Shinkai A; Izuchi R; Azuma Y
    Kekkaku; 1987 Jun; 62(6):329-39. PubMed ID: 3656859
    [No Abstract]   [Full Text] [Related]  

  • 56. Chemotherapy of tuberculosis for the 1980's.
    Dutt AK; Stead WW
    Clin Chest Med; 1980 May; 1(2):243-52. PubMed ID: 6794977
    [No Abstract]   [Full Text] [Related]  

  • 57. [Some current problems in initial chemotherapy of pulmonary tuberculosis].
    Ionesco C; Pirozynski M
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(4):883-8. PubMed ID: 5164529
    [No Abstract]   [Full Text] [Related]  

  • 58. Short-course chemotherapy in clinical practice.
    Tala E
    Scand J Respir Dis Suppl; 1978; 102():43-7. PubMed ID: 356258
    [No Abstract]   [Full Text] [Related]  

  • 59. [Characteristics of the course of pulmonary tuberculosis caused by Mycobacterium bovis].
    Kochetov BI; Dolzhanskiĭ VM; Nemsadze MN
    Probl Tuberk; 1980 Feb; (2):23-6. PubMed ID: 6990406
    [No Abstract]   [Full Text] [Related]  

  • 60. [Use of rifadin in suppositories in the combined therapy of patients with destructive forms of pulmonary tuberculosis].
    German AK; Syrovatka IuA; Bondarenko VP
    Vrach Delo; 1985 Oct; (10):98-100. PubMed ID: 4090447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.